Unique ID issued by UMIN | UMIN000009055 |
---|---|
Receipt number | R000010628 |
Scientific Title | Low-dose Whole Brain Radiation Therapy combined with Stereotactic Radiosurgery for Brain Metastases: Multi-institutional Phase II study (JROSG13-1) |
Date of disclosure of the study information | 2012/10/09 |
Last modified on | 2019/04/12 12:50:06 |
Low-dose Whole Brain Radiation Therapy combined with Stereotactic Radiosurgery for Brain Metastases: Multi-institutional Phase II study (JROSG13-1)
Low-dose Whole Brain Radiation Therapy combined with Stereotactic Radiosurgery for Brain Metastases: Multi-institutional Phase II study (JROSG13-1)
Low-dose Whole Brain Radiation Therapy combined with Stereotactic Radiosurgery for Brain Metastases: Multi-institutional Phase II study (JROSG13-1)
Low-dose Whole Brain Radiation Therapy combined with Stereotactic Radiosurgery for Brain Metastases: Multi-institutional Phase II study (JROSG13-1)
Japan |
Brain metastases
Radiology |
Malignancy
NO
To investigate the feasibility of low-dose whole brain radiotherapy (25 Gy in 10 fractions) combined with stereotactic irradiation for 1-4 brain metastatic patients
Efficacy
Exploratory
Pragmatic
Phase II
Development rate of distant brain metastases at 6-month after treatment
1) Neurocognitive function at 4-month
2) Neurocognitive function at 12-month
3) Local tumor control of brain metastases
4) Overall survival
5) Cause of death
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Maneuver |
Low-dose whole brain radiotherapy (25 Gy in 10 fractions)
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Age: 20-80 years old
2) Systemic status: KPS >= 70
3) Histopathologically confirmed
3) Indication for stereotactic irradiation (number of brain metastases, 4 or less, maximum tumor diameter, 3 cm of less)
5) Consent to neurocognitive fuctional tests and QOL questionnaire
6) Consent to this study
1) severe decline in neurocognitive function or language ability at baseline
2) history of brain radiation therapy
3) history of brain surgery of brain metastases
4) small cell carcinoma, germinoma, lymphoma
5) any other reasons not to fit to this study
70
1st name | Hidefumi |
Middle name | |
Last name | Aoyama |
Niigata University Graduate School of Medical and Dental Sciences
Radiology
9518510
1-757 Asahimachi-dori, Chuo-ku, Niigata, 9518510
025-227-2315
jrosg13-1@med.niigata-u.ac.jp
1st name | Hidefumi |
Middle name | |
Last name | Aoyama |
Niigata Univerisity Graduate School of Medical and Dental Sciences
Radiology
9518510
1-757 Asahimachi-dori, Chuo-ku, 9518510
025-227-2315
http://www.jrosg.jp/protocol/protocol_list.html
jrosg13-1@med.niigata-u.ac.jp
Niigata University, Dept of Radiology,
Japanese Radiation Oncology Study Group
JSJP
Niigata University Funding for Support for Clinical Study
Self funding
Japan
Niigata University Hospital
1-754 Asahimachi-dori, Niigata
025-227-0730
smaru@dent.niigata-u.ac.jp
YES
JROSG 13-1
Japanese Radiation Oncology Study Group
新潟大学医歯学総合研究科(新潟県)、県立がんセンター新潟病院(新潟県)、琉球大学附属病院(沖縄県)、埼玉県立がんセンター(埼玉県)、国立がん研究センター中央病院(東京)、熊本大学、北海道大学(北海道)、北海道がんセンター(北海道)
2012 | Year | 10 | Month | 09 | Day |
http://www.jrosg.jp/protocol/file/JROSG13-1_20150630-2.pdf
Unpublished
No longer recruiting
2012 | Year | 03 | Month | 28 | Day |
2012 | Year | 03 | Month | 28 | Day |
2012 | Year | 05 | Month | 01 | Day |
2019 | Year | 11 | Month | 30 | Day |
2012 | Year | 10 | Month | 06 | Day |
2019 | Year | 04 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010628